Overview

A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye

Status:
Completed
Trial end date:
2015-03-17
Target enrollment:
0
Participant gender:
All
Summary
This study will evaluate the safety and efficacy of OPTIVE FUSION™ compared to VISMED® Multi for the management of dry eye.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Allergan
Treatments:
Carboxymethylcellulose Sodium
Glycerol
Hyaluronic Acid
Criteria
Inclusion Criteria:

- Use of artificial tears for dry eye in both eyes for at least 3 months

- Use of preservative-free artificial tears at least twice daily for 2 weeks;

Exclusion Criteria:

- Cataract, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy
(PRK) surgery in the last 12 months

- Use of punctal plugs or contact lenses in the last month

- Active ocular allergy within last 2 years

- Best corrected visual acuity (BCVA) less than 20/200 in either eye